Key Metrics 
10 Yrs X-Ray 
Valuation 
Analyst Note 
Qtr. Results 
Financials 
News 
About
Siemens Healthcare Diagnostics Ltd (506559)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 506559 NSE: Hospital & Healthcare Services | Small Cap | Siemens Health. Diag Share Price
BSE Share Price
Not Listed
Not Listed
Siemens Healthcare Diagnostics Ltd (506559)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 506559 NSE: Hospital & Healthcare Services | Small Cap | Siemens Health. Diag Share Price
BSE Share Price
Not Listed
Not Listed
Key Metrics
Valuation Multiples
Market Cap
₹271 Cr.
Current Price
₹0
52-Week Low / High
₹1,715 / 1,734
TTM EPS
-
TTM Sales
-
Book Value per Share
-
P/E Ratio
Industry PE
98.5
Price to Book (P/B)
Price to Sales (P/S)
EV/EBITDA
Dividend Yield
NAN%
Profitability Efficiency
Return on Equity (ROE)
%
Return on Capital Employed (ROCE)
%
Return on Assets (ROA)
%
Operating Profit Margin
0%
Net Profit Margin
-%
Gross Profit Margin
0%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
Slowing versus 3-year growth rate
5.21%
Operating Profit Growth (1 Year)
-
-
Net Profit Growth (1 Year)
-
-
Asset Quality
Promoter Holding
68.73%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
-
Equity
₹1.6 Cr.
Face Value
₹10
All Time Low / High
₹45.00 / 1877.90
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation ⓘ
| Dec'01 | Dec'02 | Dec'03 | Dec'04 | Dec'05 | Dec'06 | Sep'07 | Sep'08 | Sep'09 | Sep'10 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | 40.5% | 35.8% | 28.2% | 27.5% | 25.4% | 80% | 12% | -6.1% | 15.1% | 19.6% | - |
Growth Parameters ⓘ |
|||||||||||
| Sales ⓘ | 48 | 52.7 | 53.2 | 61.7 | 68.3 | 74.5 | 71.8 | 102 | 168 | 176 | 174 |
| Sales YoY Gr. | - | 9.9% | 1% | 15.9% | 10.8% | 9% | -3.6% | 42.3% | 64.2% | 5.2% | - |
| Adj EPS ⓘ | 34.4 | 35.7 | 34 | 36 | 37.5 | 53.5 | 28.5 | 30.4 | 25.1 | 33.5 | 52.6 |
| YoY Gr. | - | 3.8% | -4.8% | 5.9% | 4.2% | 42.9% | -46.7% | 6.4% | -17.4% | 33.4% | - |
| BVPS (₹) ⓘ | 130.7 | 157.8 | 183.3 | 211.1 | 240.2 | 287.8 | 406.6 | 289.4 | 311.5 | 352.9 | 358.4 |
| Adj Net Profit ⓘ | 5.4 | 5.6 | 5.3 | 5.6 | 5.9 | 8.4 | 4.5 | 4.8 | 3.9 | 5.2 | 8 |
| Cash Flow from Ops. ⓘ | 5.5 | 6.3 | 9.8 | 11.1 | 10.5 | 10.1 | 0.6 | 35.9 | 57.1 | 12.2 | - |
| Debt/CF from Ops. ⓘ | 0.3 | 0.3 | 0.2 | 0.2 | 0.3 | 0.3 | 0 | 0 | 0.7 | 3.3 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | 15.6% | 20.9% | 34.9% | 5.2% | ||||
| Adj EPS ⓘ | -0.3% | -2.2% | 5.5% | 33.4% | ||||
| BVPSⓘ | 11.7% | 8% | -4.6% | 13.3% | ||||
| Share Price | - | - | - | - | ||||
Key Financial Parameters ⓘ
| Dec'01 | Dec'02 | Dec'03 | Dec'04 | Dec'05 | Dec'06 | Sep'07 | Sep'08 | Sep'09 | Sep'10 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 29.1 | 24.7 | 19.9 | 18.2 | 16.6 | 20.3 | 7.2 | 10.2 | 8.3 | 10.1 | 14.8 |
| Op. Profit Mgn % ⓘ | 14.5 | 15 | 15.3 | 15.5 | 17.6 | 16.8 | 14.6 | 14.7 | 16.5 | 19.9 | 23.9 |
| Net Profit Mgn % ⓘ | 11.2 | 10.6 | 10 | 9.1 | 8.6 | 11.3 | 6.2 | 4.7 | 2.3 | 3 | 4.7 |
| Debt to Equity ⓘ | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0 | 0 | 0.8 | 0.7 | - |
| Working Cap Days ⓘ | 181 | 150 | 175 | 178 | 158 | 146 | 184 | 153 | 165 | 167 | 40 |
| Cash Conv. Cycle ⓘ | 111 | 114 | 105 | 72 | 57 | 49 | 80 | -17 | -43 | -52 | 9 |
Valuation of Siemens Health. Diag - Consolidated
Analyst's Notes
No data found!
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
* Pledged shares as % of Promoter's holding (%)
Financials
No data found!
No data found!
No data found!
No data found!
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
Siemens Healthcare Diagnostics Ltd FAQs
The current trading price of Siemens Health. Diag on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Siemens Health. Diag stood at ₹270.6 Cr
The latest P/E ratio of Siemens Health. Diag as of 31-Dec-1969 is 32.82.
The latest P/B ratio of Siemens Health. Diag as of 31-Dec-1969 is 4.82.
The 52-week high of Siemens Health. Diag is ₹1,734 and the 52-week low is ₹1,715.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Siemens Health. Diag is ₹174 ( Cr.) .
Data is not available for this company.
No data found
No data found
About Siemens Healthcare Diagnostics Ltd
Siemens Healthcare Diagnostics is the largest clinical diagnostics company in the world, serving a critical role in the health care continuum. It offers products and services designed for efficient delivery of patient test results used for diagnosing medical conditions, monitoring patient therapy and providing quality healthcare.
Built on a rich history of innovation from Diagnostic Products Corporation, Bayer HealthCare Diagnostics and Dade Behring, the company offers comprehensive solutions designed to improve clinical outcomes, streamline workflow and enhance the operational efficiency of clinical laboratories.
Siemens Healthcare Diagnostics offers a broad portfolio of performance-driven diagnostics solutions that provide more effective ways to assist in the diagnosis, monitoring and management of disease. Its products and services offers the right balance of science, technology and practicality across the healthcare continuum to provide healthcare professionals with the vital information they need to deliver better, more personalized healthcare to patients around the globe.
The company's broad portfolio of innovative products include a variety of diagnostic systems—integrated chemistry, immunoassay, routine chemistry, automation, hematology, hemostasis, microbiology, diabetes, urinalysis, blood gas monitoring and molecular testing. Its dedicated professionals are committed to meet the needs of their customers by providing high-quality products and highly-responsive service and support.
Product range of the company includes:
Point of Care
- Blood Gas
- Diabetes
- Urinalysis
- Cardiology
Molecular Diagnostics
- Molecular Diagnostics
Disease States
- Allergy
- Cardiovascular Disease
- Liver Disease
- Oncology
Integrated Diagnostics
- Integrated Diagnostics
Siemens Healthcare Portfolio
- Diagnostic Imaging, Therapy & IT
You have 47 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
